Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Filings indexed 524 across all filing types
Latest filing 2011-04-06 Report Publication Anno…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage AB (publ) publishes its 2010 Annual Report
Report Publication Announcement Classification · 99% confidence The document text is very short (around 1000 characters) and appears to be a press release snippet. It contains a standard disclaimer about regulatory disclosure requirements ("The information in this press release is of the kind that Biotage AB (publ) may be required to make public according to the Securities Market Act...") and specifies the release time and date (April 6, 2011). It does not contain detailed financial figures characteristic of an ER, IR, or 10-K, nor does it explicitly announce a specific report's availability (RPA). Given the nature of a brief, mandatory disclosure announcement that doesn't fit a more specific category like DIRS, DIV, or MANG, the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2011-04-06 English
KALLELSE TILL ÅRSSTÄMMA I BIOTAGE AB (publ)
AGM Information Classification · 98% confidence The document is titled "KALLELSE TILL ÅRSSTÄMMA I BIOTAGE AB (publ)" which translates to "NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)". It details the date, time, location, registration procedures, agenda items (including election of board members, approval of financial statements, dividend proposal, and capital structure changes), and proposals related to the upcoming shareholder meeting. This content is characteristic of a formal notice or proxy material for an Annual General Meeting (AGM). While it contains proposals that might be voted on, the primary function is the 'Kallelse' (Notice) and the associated materials for the meeting itself. This aligns best with the AGM Information category (AGM-R), which covers presentations and materials shared during the AGM. It is not a DEF 14A (Remuneration) or a DVA (Voting Results), but the notice/material for the meeting itself.
2011-03-25 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)" and details the date, location, shareholder requirements for participation, and a detailed proposed agenda for the meeting. The agenda items cover standard AGM topics like election of the chairman, approval of financial statements, discharge from liability, board elections, compensation, and specific proposals regarding share capital reduction and bonus issues. This content directly corresponds to the definition of materials shared during an Annual General Meeting.
2011-03-25 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document details a change in shareholding for 'Home Capital AS' in 'Biotage AB'. It explicitly states the 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of shares and voting rights (crossing the 5% threshold). This structure perfectly matches the definition of a Major Shareholding Notification.
2011-03-24 English
Following Biotage’s request for re-examination US Patent and Trademark Office has rejected all claims in US patent 7,381,327
Legal Proceedings Report Classification · 98% confidence The document is a press release from Biotage AB dated March 16, 2011, detailing the outcome of a re-examination request filed with the US Patent and Trademark Office regarding a patent infringement lawsuit. This announcement concerns a significant legal matter involving the company's intellectual property and ongoing litigation. Based on the provided definitions, the category 'Legal Proceedings Report (Code: LTR)' best fits a document providing updates on significant lawsuits or regulatory actions involving the company. The document is short and is a direct announcement, not a comprehensive financial report.
2011-03-16 English
Amerikanska patentverket ogiltigförklarar samtliga patenkrav i US patent 7,381,327 efter Biotages begäran om omprövning av giltigheten av desamma.
Legal Proceedings Report Classification · 95% confidence The document is a press release dated March 16, 2011, announcing a specific legal/regulatory outcome: the US Patent Office invalidated all claims in US patent 7,381,327 following Biotage's request for reexamination. This directly relates to ongoing patent infringement litigation mentioned in the text. This type of announcement concerning significant lawsuits or regulatory actions affecting the company fits best under the 'Legal Proceedings Report' (LTR) category, as it details the status of a legal matter (patent dispute). It is not a general regulatory filing (RNS) because it is highly specific to a legal proceeding, nor is it an earnings release, management report, or capital event.
2011-03-16 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.